Data / Form D filings / TENAX THERAPEUTICS, INC.
TENAX THERAPEUTICS, INC.: Form D filings
TENAX THERAPEUTICS, INC., a pharmaceuticals company in Chapel Hill, NC, filed 11 Form D notices with the SEC between 2009 and 2024. The latest, on August 23, 2024, reports $99.7 million sold of a $175 million offering to 24 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 101 GLEN LENNOX DRIVE, SUITE 300, Chapel Hill, NC, 27517
- Phone
- (919) 855-2100
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 34956
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 23, 2024 | New notice | $174,999,993 | $99,681,169 | $75,318,824 | 24 | Aug 8, 2024 | sec.gov |
| Jun 1, 2022 | New notice | $8,000,000 | $8,000,000 | 1 | May 17, 2022 | sec.gov | |
| Jul 20, 2021 | New notice | $9,999,998 | $9,999,998 | 1 | Jul 8, 2021 | sec.gov | |
| Jul 22, 2020 | New notice | $5,173,587 | $5,173,587 | 1 | Jul 8, 2020 | sec.gov | |
| Mar 27, 2020 | New notice | $317,167 | $317,167 | 1 | Mar 13, 2020 | sec.gov | |
| Nov 29, 2013 | New notice | $6,579,122 | $6,579,122 | 4 | Nov 13, 2013 | sec.gov | |
| Sep 3, 2013 | New notice | $4,600,000 | $4,600,000 | 1 | Aug 22, 2013 | sec.gov | |
| Aug 7, 2013 | New notice | $52,900 | $52,900 | 1 | Jul 23, 2013 | sec.gov | |
| Mar 8, 2013 | New notice | $2,100,000 | $2,100,000 | 2 | Feb 27, 2013 | sec.gov | |
| Jun 22, 2009 | New notice | $1,917,000 | $0 | $1,917,000 | 0 | Yet to occur | sec.gov |
| Jun 10, 2009 | New notice | $21,000,000 | $5,250,000 | $15,750,000 | 2 | Jun 8, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael R. Davidson | Director | |
| Stuart M. Rich | Executive Officer, Director | |
| Lawrence R. Hoffman | Executive Officer | |
| Christopher T. Giordano | Executive Officer, Director | |
| Declan R. Doogan | Director | |
| June M. Almenoff | Director | |
| Robyn M. Hunter | Director | |
| Gerald T. Proehl | Director |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Aug 19, 2024 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TENAX THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.